Abbvie Inc
NYSE:ABBV
Abbvie Inc
Cash Paid for Dividends
Abbvie Inc
Cash Paid for Dividends Peer Comparison
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Cash Paid for Dividends
-$10.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-15%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Paid for Dividends
-$3.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Paid for Dividends
-$4.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-12%
|
|
Moderna Inc
NASDAQ:MRNA
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Cash Paid for Dividends?
Cash Paid for Dividends
-10.5B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Cash Paid for Dividends amounts to -10.5B USD.
What is Abbvie Inc's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-15%
Over the last year, the Cash Paid for Dividends growth was -5%. The average annual Cash Paid for Dividends growth rates for Abbvie Inc have been -11% over the past three years , -14% over the past five years , and -15% over the past ten years .